RAM Pharmaceuticals Inc.
View this filing on EDGAR (filing index, accession 0001665160-25-000208) | All Form C filings by this company on EDGAR
Filing details
| Company | RAM Pharmaceuticals Inc. | (Form C, issuer information) |
|---|---|---|
| State | MS | (Form C, issuer information) |
| Platform | StartEngine Primary, LLC | (Form C, issuer information) |
| Filing date | 2025-02-10 | (EDGAR filing index) |
| Date of incorporation | 2024-11-11 | (Form C, issuer information) |
| Employees | 1 | (Form C, issuer information) |
| Security offered | Other Series B Common Stock | (Form C, offering information) |
| Price per security | $1 | (Form C, offering information) |
| Target amount | $124,000 | (Form C, offering information) |
| Maximum ask | $1,235,000 | (Form C, offering information) |
| Offering deadline | 2025-04-30 | (Form C, offering information) |
| Platform compensation | 7 - 13 percent | (Form C, offering information) |
Financial summary
Figures are as entered by the company in the financial summary on the cover of its Form C. They are self-reported and unaudited, and they are not taken from the financial statements filed as exhibits to the Form C, which we do not read mechanically.
| Item | Most recent fiscal year | Prior fiscal year | Source |
|---|---|---|---|
| Revenue | $1,970 | $17,535 | (Form C, financial summary) |
| Cost of goods sold | $2,232 | $11,405 | (Form C, financial summary) |
| Net income | -$230,467 | -$265,801 | (Form C, financial summary) |
| Taxes paid | $0 | $0 | (Form C, financial summary) |
| Cash and equivalents | $23,438 | $213,281 | (Form C, financial summary) |
| Accounts receivable | $0 | $0 | (Form C, financial summary) |
| Total assets | $43,537 | $222,770 | (Form C, financial summary) |
| Short-term debt | $65,190 | $43,337 | (Form C, financial summary) |
| Long-term debt | $65,190 | $43,337 | (Form C, financial summary) |
Mechanical checks that fired
- Going-concern language. Going-concern language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The quoted sentence is below. Read the auditor or accountant notes in the filing for the full context. Found in: 0002053710-25-000005, 0002053710-25-000007, 0002053710-26-000001.
"GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern."
"GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern."
- Related-party language. Related-party language appears in this offering's own Form C filing or in an amendment to it, in a sentence that states it rather than ruling it out. The phrase can describe routine or unusual arrangements, so read the quoted sentence and the filing. Found in: 0002053710-25-000005, 0002053710-25-000007, 0002053710-26-000001.
"Related Party Transactions During the year, the Company borrowed funds from a related party, RAM Consulting, LLC, which is owned by Richard A."
"Related Party Transactions During the year, the Company borrowed funds from a related party, RAM Consulting, LLC, which is owned by Richard A."
- Net loss in both years. Net income is negative in both fiscal years reported in the Form C financial summary.
- Cash below one year of losses. Net loss for the most recent fiscal year is larger than year-end cash, both as reported in the Form C financial summary.
- Debt above assets. Short-term plus long-term debt is larger than total assets in the Form C financial summary.
- Maximum ask above 10x revenue. The maximum offering amount is more than 10 times the most recent fiscal year revenue (or revenue is $0), per the Form C.
- Repeat Form C filer. This company filed 2 or more new Form C filings between 2024-10-21 to 2026-10-27 on EDGAR.
- Platform compensation of 8% or more. The platform compensation stated in the Form C is 8% or more of the offering.
A check means "read this part of the filing closely." It is not a judgment about how the company will do.
Other Form C filings by this company in our data
Company website as listed in the Form C: https://rampharmaceuticals.com
Want the weekly briefing? Subscribe free.